Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pyrazoloacridine (PD 115934) is a nucleic acid binding agent that inhibits the activity of topo I and II with an IC50 of 1.25 μM in K562 cells. Pyrazoloacridine shows anti-cancer activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $36 | In Stock | |
5 mg | $88 | In Stock | |
10 mg | $143 | In Stock | |
25 mg | $286 | In Stock | |
50 mg | $413 | In Stock | |
100 mg | $589 | In Stock | |
500 mg | $1,170 | In Stock |
Description | Pyrazoloacridine (PD 115934) is a nucleic acid binding agent that inhibits the activity of topo I and II with an IC50 of 1.25 μM in K562 cells. Pyrazoloacridine shows anti-cancer activity. |
In vitro | In oxic and hypoxic HCT-8 cells, Pyrazoloacridine exhibits IC50 values of 10.7 μM and 4.5 μM[2]. Pyrazoloacridine causes delayed DNA fragmentation in MCF-7 cells and induces apoptosis in P53-deficient Hep 3B cells. Pyrazoloacridine exhibits activities against cisplatin- and paclitaxel-resistant ovarian cancer[3]. |
Alias | PD-115934, PD 115934, PD 115,934, NSC-366140, NSC 366140 |
Molecular Weight | 367.4 |
Formula | C19H21N5O3 |
Cas No. | 99009-20-8 |
Smiles | COc1ccc2[nH]c3c(ccc4n(CCCN(C)C)nc(c34)c2c1)[N+]([O-])=O |
Relative Density. | 1.314g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: 1 mg/ml, Sonication is recommended. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.